| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 52 | +75.00% | -4.46% | -0.81% | -3.66% | -4.88% | -2.41 |
| 14d | 52 | +59.62% | -2.58% | -0.66% | -1.93% | -6.26% | -0.73 |
| 30d | 52 | +69.23% | -7.67% | -0.61% | -7.06% | -7.21% | -2.83 |
| 60d | 52 | +46.15% | -4.16% | +1.19% | -5.35% | -10.04% | -1.66 |
| 90d | 52 | +44.23% | -4.81% | +2.00% | -4.32% | -2.32% | -1.01 |
| 180d | 52(4 pending) | +62.50% | -8.46% | +4.91% | -13.39% | -18.01% | -2.62 |
| 1y | 52(8 pending) | +45.45% | -14.23% | +9.36% | -23.59% | -28.16% | -2.50 |
| 2y | 52(18 pending) | +26.47% | -9.06% | +23.94% | -32.99% | -44.82% | -2.95 |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| NUVL NUVALENT, INC. | PURCHASEGRANT Stock grant | 3,444 | — | — | 3,444 | Jun 16, 2026 | Jun 18, 2026 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 55,150 | — | — | 55,150 | May 19, 2026 | May 20, 2026 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 1,084,012 | $5.00 | $5.42M | 10,622,957 | Feb 27, 2026 | Mar 2, 2026 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 831,978 | $5.00 | $4.16M | 8,153,107 | Feb 27, 2026 | Mar 2, 2026 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 2,000,000 | $5.00 | $10.00M | 6,207,982 | Feb 27, 2026 | Mar 2, 2026 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 1,084,010 | $5.00 | $5.42M | 10,622,928 | Feb 27, 2026 | Mar 2, 2026 ↗ | View → |
| NUVL NUVALENT, INC. | SALE | 371,287 | $95.45 | $35.44M | 8,299,225 | Nov 24, 2025 | Nov 24, 2025 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 2,599,932 | $3.20 | $8.32M | 7,321,129 | Jul 31, 2025 | Aug 4, 2025 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 3,387,529 | $3.20 | $10.84M | 9,538,918 | Jul 31, 2025 | Aug 4, 2025 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 3,387,539 | $3.20 | $10.84M | 9,538,945 | Jul 31, 2025 | Aug 4, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE | 370,074 | $18.46 | $6.83M | 4,887,254 | Jun 27, 2025 | Jul 1, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE | 370,075 | $18.46 | $6.83M | 4,887,254 | Jun 27, 2025 | Jul 1, 2025 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASEGRANT Stock grant | 4,147 | — | — | 4,147 | Jun 18, 2025 | Jun 20, 2025 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASEGRANT Stock grant | 2,647 | — | — | 2,647 | Jun 18, 2025 | Jun 20, 2025 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,000 | — | — | 19,000 | May 13, 2025 | May 15, 2025 ↗ | View → |
| PHGE BIOMX INC. | PURCHASEGRANT Stock grant | 1,611,864 | — | — | 1,611,864 | Apr 21, 2025 | Apr 23, 2025 ↗ | View → |
| PHGE BIOMX INC. | PURCHASEGRANT Stock grant | 17,600 | — | — | 17,600 | Apr 14, 2025 | Apr 18, 2025 ↗ | View → |
| PHGE BIOMX INC. | PURCHASEGRANT Stock grant | 1,258,614 | — | — | 1,258,614 | Feb 27, 2025 | Mar 3, 2025 ↗ | View → |
| PHGE BIOMX INC. | PURCHASE | 353,249 | $0.93 | $328.7K | 1,247,054 | Feb 27, 2025 | Mar 3, 2025 ↗ | View → |
| PHGE BIOMX INC. | SALE | 1,611,863 | — | — | 405,637 | Feb 27, 2025 | Mar 3, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE | 9,553 | $17.77 | $169.8K | 5,257,328 | Nov 12, 2024 | Nov 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE | 7,853 | $17.16 | $134.8K | 5,266,883 | Nov 12, 2024 | Nov 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE | 7,854 | $17.16 | $134.8K | 5,266,881 | Nov 12, 2024 | Nov 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE | 9,554 | $17.77 | $169.8K | 5,257,329 | Nov 12, 2024 | Nov 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE | 40,596 | $17.45 | $708.4K | 5,498,368 | Nov 11, 2024 | Nov 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE | 40,596 | $17.45 | $708.4K | 5,498,367 | Nov 11, 2024 | Nov 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE | 223,632 | $18.15 | $4.06M | 5,274,735 | Nov 11, 2024 | Nov 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE | 223,632 | $18.15 | $4.06M | 5,274,736 | Nov 11, 2024 | Nov 13, 2024 ↗ | View → |
| NUVL NUVALENT, INC. | SALE | 1,000,000 | $97.75 | $97.75M | 8,670,512 | Oct 22, 2024 | Oct 24, 2024 ↗ | View → |
| BCAX BICARA THERAPEUTICS INC. | PURCHASE | 35,000 | $18.00 | $630.0K | 897,587 | Sep 17, 2024 | Sep 17, 2024 ↗ | View → |
| BCAX BICARA THERAPEUTICS INC. | PURCHASE | 862,587 | — | — | 862,587 | Sep 17, 2024 | Sep 17, 2024 ↗ | View → |
| BCAX BICARA THERAPEUTICS INC. | SALE | 7,973,325 | — | — | 0 | Sep 17, 2024 | Sep 17, 2024 ↗ | View → |
| PHGE BIOMX INC. | SALE | 5,883 | — | — | 47,957 | Jul 15, 2024 | Jul 17, 2024 ↗ | View → |
| PHGE BIOMX INC. | PURCHASE | 5,883,000 | — | — | 8,938,049 | Jul 15, 2024 | Jul 17, 2024 ↗ | View → |
| PHGE BIOMX INC. | PURCHASEGRANT Stock grant | 264,000 | — | — | 264,000 | Jul 11, 2024 | Jul 15, 2024 ↗ | View → |
| PHGE BIOMX INC. | PURCHASEGRANT Stock grant | 20,175,000 | — | — | 20,175,000 | Jul 9, 2024 | Jul 11, 2024 ↗ | View → |
| PHGE BIOMX INC. | PURCHASEGRANT Stock grant | 722,175 | — | — | 722,175 | Jul 9, 2024 | Jul 11, 2024 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASEGRANT Stock grant | 3,789 | — | — | 3,789 | Jun 12, 2024 | Jun 14, 2024 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASEGRANT Stock grant | 2,499 | — | — | 2,499 | Jun 12, 2024 | Jun 14, 2024 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,000 | — | — | 19,000 | May 29, 2024 | Jun 3, 2024 ↗ | View → |
| PHGE BIOMX INC. | PURCHASEGRANT Stock grant | 40,350 | — | — | 53,840 | Mar 15, 2024 | Mar 19, 2024 ↗ | View → |
| PHGE BIOMX INC. | PURCHASEGRANT Stock grant | 3,055,049 | — | — | 3,055,049 | Mar 15, 2024 | Mar 19, 2024 ↗ | View → |
| PHGE BIOMX INC. | PURCHASEGRANT Stock grant | 13,490 | — | — | 13,490 | Mar 15, 2024 | Mar 19, 2024 ↗ | View → |
| AHCO ADAPTHEALTH CORP. | SALE | 114,906 | $10.70 | $1.23M | 11,528,863 | Mar 12, 2024 | Mar 12, 2024 ↗ | View → |
| AHCO ADAPTHEALTH CORP. | SALE | 94,567 | $10.92 | $1.03M | 11,731,809 | Mar 11, 2024 | Mar 12, 2024 ↗ | View → |
| AHCO ADAPTHEALTH CORP. | SALE | 88,040 | $11.13 | $979.9K | 11,643,769 | Mar 11, 2024 | Mar 12, 2024 ↗ | View → |
| AHCO ADAPTHEALTH CORP. | SALE | 4,495 | $11.03 | $49.6K | 11,826,376 | Mar 8, 2024 | Mar 12, 2024 ↗ | View → |
| AHCO ADAPTHEALTH CORP. | SALE | 47,992 | $10.92 | $524.1K | 11,830,871 | Mar 8, 2024 | Mar 12, 2024 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 1,430,205 | $8.74 | $12.50M | 4,207,982 | Feb 16, 2024 | Feb 16, 2024 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 1,430,206 | $8.74 | $12.50M | 6,151,406 | Feb 16, 2024 | Feb 16, 2024 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 1,430,206 | $8.74 | $12.50M | 6,151,389 | Feb 16, 2024 | Feb 16, 2024 ↗ | View → |
| GUTS FRACTYL HEALTH, INC. | SALE | 164,612 | — | — | 0 | Feb 6, 2024 | Feb 6, 2024 ↗ | View → |
| GUTS FRACTYL HEALTH, INC. | SALE | 1,625,699 | — | — | 0 | Feb 6, 2024 | Feb 6, 2024 ↗ | View → |
| GUTS FRACTYL HEALTH, INC. | PURCHASE | 757,548 | — | — | 757,548 | Feb 6, 2024 | Feb 6, 2024 ↗ | View → |
| GUTS FRACTYL HEALTH, INC. | PURCHASE | 76,706 | — | — | 834,254 | Feb 6, 2024 | Feb 6, 2024 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | Jun 15, 2023 | Jun 16, 2023 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 8,300 | — | — | 8,300 | May 9, 2023 | May 11, 2023 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASE | 650,000 | $33.50 | $21.77M | 650,000 | Nov 3, 2022 | Nov 7, 2022 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 2,777,777 | $3.15 | $8.75M | 4,721,183 | Sep 16, 2022 | Sep 20, 2022 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 2,777,777 | $3.15 | $8.75M | 2,777,777 | Sep 16, 2022 | Sep 20, 2022 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 2,777,777 | $3.15 | $8.75M | 4,721,200 | Sep 16, 2022 | Sep 20, 2022 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 2,777,777 | $3.15 | $8.75M | 4,721,197 | Sep 16, 2022 | Sep 20, 2022 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | Jun 16, 2022 | Jun 21, 2022 ↗ | View → |
| MIRM MIRUM PHARMACEUTICALS, INC. | SALE | 171 | $25.08 | $4.3K | 1,711,153 | Jun 6, 2022 | Jun 8, 2022 ↗ | View → |
| MIRM MIRUM PHARMACEUTICALS, INC. | SALE | 6,243 | $24.47 | $152.8K | 1,540,190 | Jun 6, 2022 | Jun 8, 2022 ↗ | View → |
| MIRM MIRUM PHARMACEUTICALS, INC. | SALE | 11,868 | $25.29 | $300.1K | 1,546,588 | Jun 6, 2022 | Jun 8, 2022 ↗ | View → |
| MIRM MIRUM PHARMACEUTICALS, INC. | SALE | 13,132 | $25.29 | $332.1K | 1,711,324 | Jun 6, 2022 | Jun 8, 2022 ↗ | View → |
| MIRM MIRUM PHARMACEUTICALS, INC. | SALE | 155 | $25.08 | $3.9K | 1,546,433 | Jun 6, 2022 | Jun 8, 2022 ↗ | View → |
| MIRM MIRUM PHARMACEUTICALS, INC. | SALE | 6,909 | $24.47 | $169.1K | 1,704,244 | Jun 6, 2022 | Jun 8, 2022 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 8,300 | — | — | 8,300 | May 10, 2022 | May 11, 2022 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASE | 268,480 | — | — | 268,480 | May 10, 2022 | May 10, 2022 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASE | 208,333 | $12.00 | $2.50M | 476,813 | May 10, 2022 | May 10, 2022 ↗ | View → |
| PEPG PEPGEN INC. | SALE | 273,313 | — | — | 0 | May 10, 2022 | May 10, 2022 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | PURCHASE | 40 | — | — | 40 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | SALE | 85,113 | — | — | 0 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | SALE | 40 | — | — | 0 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | PURCHASE | 85,113 | — | — | 85,113 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | PURCHASE | 50,000 | $1,000.00 | $50.00M | 58,945 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | PURCHASE | 3,177,543 | — | — | 3,177,543 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | SALE | 14,887 | — | — | 85,113 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | PURCHASE | 625,000 | — | — | 625,000 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | SALE | 707,960 | — | — | 40 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 756,472 | — | — | 756,472 | Oct 26, 2021 | Oct 28, 2021 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE | 7,186,489 | — | — | 0 | Oct 26, 2021 | Oct 28, 2021 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 387,500 | $16.00 | $6.20M | 1,143,972 | Oct 26, 2021 | Oct 28, 2021 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASE | 897,671 | — | — | 9,670,511 | Aug 2, 2021 | Aug 4, 2021 ↗ | View → |
| NUVL NUVALENT, INC. | SALE | 45,716,568 | — | — | 13,011,988 | Aug 2, 2021 | Aug 4, 2021 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASE | 300,000 | $17.00 | $5.10M | 2,717,628 | Aug 2, 2021 | Aug 4, 2021 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASE | 2,417,628 | — | — | 2,417,628 | Aug 2, 2021 | Aug 4, 2021 ↗ | View → |
| NUVL NUVALENT, INC. | SALE | 4,831,384 | — | — | 0 | Aug 2, 2021 | Aug 4, 2021 ↗ | View → |
| NUVL NUVALENT, INC. | SALE | 13,011,988 | — | — | 0 | Aug 2, 2021 | Aug 4, 2021 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASE | 8,494,140 | — | — | 8,772,840 | Aug 2, 2021 | Aug 4, 2021 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASEGRANT Stock grant | 43,000 | — | — | 43,000 | Jul 28, 2021 | Jul 30, 2021 ↗ | View → |
| MIRM MIRUM PHARMACEUTICALS, INC. | SALE | 99,325 | $15.81 | $1.57M | 0 | Jul 9, 2021 | Jul 13, 2021 ↗ | View → |
| MIRM MIRUM PHARMACEUTICALS, INC. | SALE | 6,837 | $15.87 | $108.5K | 99,325 | Jul 7, 2021 | Jul 7, 2021 ↗ | View → |
| MIRM MIRUM PHARMACEUTICALS, INC. | SALE | 49,239 | $16.20 | $797.4K | 106,162 | Jul 6, 2021 | Jul 7, 2021 ↗ | View → |
| MIRM MIRUM PHARMACEUTICALS, INC. | SALE | 10,599 | $17.01 | $180.3K | 155,401 | Jul 2, 2021 | Jul 7, 2021 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 228,571 | $8.75 | $2.00M | 1,943,423 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 228,569 | $8.75 | $2.00M | 1,943,406 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 228,570 | $8.75 | $2.00M | 1,943,420 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 8,300 | — | — | 8,300 | May 12, 2021 | May 17, 2021 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | SALE | 15,195,094 | — | — | 0 | May 4, 2021 | May 4, 2021 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASE | 800,000 | $16.00 | $12.80M | 2,552,787 | May 4, 2021 | May 4, 2021 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASE | 1,752,787 | — | — | 1,752,787 | May 4, 2021 | May 4, 2021 ↗ | View → |
| EWTX EDGEWISE THERAPEUTICS, INC. | PURCHASE | 1,301,626 | — | — | 2,874,586 | Mar 30, 2021 | Mar 30, 2021 ↗ | View → |
| EWTX EDGEWISE THERAPEUTICS, INC. | SALE | 1,301,626 | — | — | 0 | Mar 30, 2021 | Mar 30, 2021 ↗ | View → |
| EWTX EDGEWISE THERAPEUTICS, INC. | PURCHASE | 625,000 | $16.00 | $10.00M | 3,933,137 | Mar 30, 2021 | Mar 30, 2021 ↗ | View → |
| EWTX EDGEWISE THERAPEUTICS, INC. | SALE | 1,572,960 | — | — | 0 | Mar 30, 2021 | Mar 30, 2021 ↗ | View → |
| EWTX EDGEWISE THERAPEUTICS, INC. | PURCHASE | 433,551 | — | — | 3,308,137 | Mar 30, 2021 | Mar 30, 2021 ↗ | View → |
| EWTX EDGEWISE THERAPEUTICS, INC. | SALE | 433,551 | — | — | 0 | Mar 30, 2021 | Mar 30, 2021 ↗ | View → |
| EWTX EDGEWISE THERAPEUTICS, INC. | PURCHASE | 1,572,960 | — | — | 1,572,960 | Mar 30, 2021 | Mar 30, 2021 ↗ | View → |
| TERN TERNS PHARMACEUTICALS, INC. | PURCHASE | 665,000 | $17.00 | $11.30M | 2,382,033 | Feb 9, 2021 | Feb 9, 2021 ↗ | View → |
| TERN TERNS PHARMACEUTICALS, INC. | PURCHASE | 1,717,033 | — | — | 1,717,033 | Feb 9, 2021 | Feb 9, 2021 ↗ | View → |
| TERN TERNS PHARMACEUTICALS, INC. | SALE | 1,717,033 | — | — | 0 | Feb 9, 2021 | Feb 9, 2021 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 16,600 | — | — | 16,600 | Sep 29, 2020 | Oct 1, 2020 ↗ | View → |
| ANNX ANNEXON, INC. | PURCHASE | 458,914 | — | — | 458,914 | Jul 28, 2020 | Jul 28, 2020 ↗ | View → |
| ANNX ANNEXON, INC. | PURCHASE | 350,000 | $17.00 | $5.95M | 808,914 | Jul 28, 2020 | Jul 28, 2020 ↗ | View → |
| ANNX ANNEXON, INC. | SALE | 4,043,031 | — | — | 0 | Jul 28, 2020 | Jul 28, 2020 ↗ | View → |
| ANNX ANNEXON, INC. | SALE | 4,043,032 | — | — | 0 | Jul 28, 2020 | Jul 28, 2020 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASE | 500,000 | $18.00 | $9.00M | 1,209,936 | Jul 14, 2020 | Jul 14, 2020 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASE | 709,936 | — | — | 709,936 | Jul 14, 2020 | Jul 14, 2020 ↗ | View → |
| NKTX NKARTA, INC. | SALE | 2,626,767 | — | — | 0 | Jul 14, 2020 | Jul 14, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | PURCHASE | 498,795 | — | — | 498,795 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | PURCHASE | 300,000 | $17.00 | $5.10M | 1,297,589 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | SALE | 498,795 | — | — | 0 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | PURCHASE | 997,589 | — | — | 997,589 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | PURCHASE | 300,000 | $17.00 | $5.10M | 798,795 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | SALE | 997,589 | — | — | 0 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| SDGR SCHRODINGER, INC. | PURCHASE | 250,000 | $17.00 | $4.25M | 250,000 | Feb 10, 2020 | Feb 10, 2020 ↗ | View → |
| SDGR SCHRODINGER, INC. | SALE | 10,063,061 | — | — | 0 | Feb 10, 2020 | Feb 10, 2020 ↗ | View → |
| SDGR SCHRODINGER, INC. | PURCHASE | 1,346,167 | — | — | 1,346,167 | Feb 10, 2020 | Feb 10, 2020 ↗ | View → |
| BDTX BLACK DIAMOND THERAPEUTICS, INC. | PURCHASE | 378,790 | — | — | 378,790 | Feb 3, 2020 | Feb 3, 2020 ↗ | View → |
| BDTX BLACK DIAMOND THERAPEUTICS, INC. | SALE | 1,142,361 | — | — | 0 | Feb 3, 2020 | Feb 3, 2020 ↗ | View → |
| BDTX BLACK DIAMOND THERAPEUTICS, INC. | PURCHASE | 400,000 | $19.00 | $7.60M | 778,790 | Feb 3, 2020 | Feb 3, 2020 ↗ | View → |